U.S. flag

An official website of the United States government

NM_000335.5(SCN5A):c.1813G>A (p.Gly605Arg) AND not provided

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Apr 4, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003441970.3

Allele description [Variation Report for NM_000335.5(SCN5A):c.1813G>A (p.Gly605Arg)]

NM_000335.5(SCN5A):c.1813G>A (p.Gly605Arg)

Gene:
SCN5A:sodium voltage-gated channel alpha subunit 5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000335.5(SCN5A):c.1813G>A (p.Gly605Arg)
HGVS:
  • NC_000003.12:g.38603789C>T
  • NG_008934.1:g.50884G>A
  • NM_000335.5:c.1813G>AMANE SELECT
  • NM_001099404.2:c.1813G>A
  • NM_001099405.2:c.1813G>A
  • NM_001160160.2:c.1813G>A
  • NM_001160161.2:c.1813G>A
  • NM_001354701.2:c.1813G>A
  • NM_198056.3:c.1813G>A
  • NP_000326.2:p.Gly605Arg
  • NP_001092874.1:p.Gly605Arg
  • NP_001092875.1:p.Gly605Arg
  • NP_001153632.1:p.Gly605Arg
  • NP_001153633.1:p.Gly605Arg
  • NP_001341630.1:p.Gly605Arg
  • NP_932173.1:p.Gly605Arg
  • NP_932173.1:p.Gly605Arg
  • LRG_289t1:c.1813G>A
  • LRG_289:g.50884G>A
  • LRG_289p1:p.Gly605Arg
  • NC_000003.11:g.38645280C>T
  • NM_198056.2:c.1813G>A
Protein change:
G605R
Links:
dbSNP: rs1553704001
NCBI 1000 Genomes Browser:
rs1553704001
Molecular consequence:
  • NM_000335.5:c.1813G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099404.2:c.1813G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099405.2:c.1813G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001160160.2:c.1813G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001160161.2:c.1813G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354701.2:c.1813G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198056.3:c.1813G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001546124Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Aug 14, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004167840GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Uncertain significance
(Apr 4, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001546124.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant has not been reported in the literature in individuals with SCN5A-related conditions. ClinVar contains an entry for this variant (Variation ID: 519522). This sequence change replaces glycine with arginine at codon 605 of the SCN5A protein (p.Gly605Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is not present in population databases (ExAC no frequency). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C65". The arginine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From GeneDx, SCV004167840.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024